Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-16T14:54:57.714Z Has data issue: false hasContentIssue false

Paliperidone palmitate: Experience in a community mental health unit

Published online by Cambridge University Press:  23 March 2020

L. Carrión Expósito
Affiliation:
, UGC-Salud Mental Hospital Infanta Margarita, Córdoba, Spain
G.M. Chauca Chauca
Affiliation:
, UGC-Salud Mental Hospital Infanta Margarita, Córdoba, Spain
E.L. Guadalupe
Affiliation:
USMC Cáceres, Hospital Nuestra Señora de la Montaña, Cáceres- Spain, Córdoba, Spain

Abstract

Introduction

There are many jobs that offer advantages of treatment with long-acting injectable in psychosis.

Objective

To know the changes in the different variables after the start of paliperidone palmitate (PP).

Material and method

We performed a descriptive and retrospective study. Were evaluated patients who received maintenance therapy with PP during 48 months.

Results

The sample was composed of 29 patients: 72.4% men and 27.6% women. Average age of 46.21 years. In Figures 1, 2 and 3 show data obtained in relation to compliance with treatment, relapse, maintenance dose, number of admissions and visits to emergency departments respectively.

Conclusions

The administration of PP is associated with a higher level of compliance with treatment. The patients presented a lower number of relapses, hospitalizations and visits to the emergency room. The maintenance dose more used is 150 mg.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster Viewing: Schizophrenia and other psychotic disorders
Copyright
Copyright © European Psychiatric Association 2017

Fig. 1

Fig. 2

Fig. 3

Figure 0

Fig. 1

Figure 1

Fig. 2

Figure 2

Fig. 3

Submit a response

Comments

No Comments have been published for this article.